| Literature DB >> 29295830 |
Abstract
Patients with severe (serum sodium ≤120 mEq/L), symptomatic hyponatremia can develop life-threatening or fatal complications from cerebral edema if treatment is inadequate and permanent neurologic disability from osmotic demyelination if treatment is excessive. Unfortunately, as is true of all electrolyte disturbances, there are no randomized trials to guide the treatment of this challenging disorder. Rather, therapeutic decisions rest on physiologic principles, animal models, observational studies, and single-patient reports. European guidelines and recommendations of an American Expert panel have come to similar conclusions on how much correction of hyponatremia is enough and how much is too much, but there are important differences. We review the evidence supporting these recommendations, identifying areas that rest on relatively solid ground and highlighting areas in greatest need of additional data.Entities:
Keywords: Animal; Animals; Brain Edema; Demyelinating Diseases; Models; Osmosis; Sodium; United States; Water-Electrolyte Imbalance; clinical nephrology; electrolytes; humans; hypokalemia; hyponatremia; osmolality
Mesh:
Substances:
Year: 2018 PMID: 29295830 PMCID: PMC5968908 DOI: 10.2215/CJN.10440917
Source DB: PubMed Journal: Clin J Am Soc Nephrol ISSN: 1555-9041 Impact factor: 8.237